Smoking abstinence and neurocognition: implications for cessation and relapse
- PMID: 25655892
- DOI: 10.1007/978-3-319-13665-3_8
Smoking abstinence and neurocognition: implications for cessation and relapse
Abstract
In this chapter, we review the last decade of research on the effects of smoking abstinence on various forms of neurocognition, including executive function (working memory, sustained attention, response inhibition), reward processing, and cue-reactivity. In our review we identify smoking abstinence-induced deficits in executive function mediated by effects on frontal circuitry, which in turn is known to be affected by modulation of cholinergic, dopaminergic, and other neurotransmitter systems. We also review evidence that smoking abstinence blunts reactivity to non-drug reinforcers-a finding that is consistent with results in the animal literature. Finally, our review of cue-reactivity indicates that smoking abstinence does not appear to amplify cue-provoked craving, although it may increase attentional bias to smoking-related cues. Inconsistencies across findings and potential contributing factors are discussed. In addition, we review the literature on the effects of nicotine and non-nicotine factors in neurocognition. Finally, we provide a multi-factor model and an agenda for future research on the effects of smoking abstinence on neurocognition. The model includes four distinct yet interacting factors, including: Negative Reinforcement, Drug-Reward Bias, Goal and Skill Interference, and Non-Cognitive Factors. Additional research is needed to further evaluate the scope and time-course of abstinence-induced changes in neurocognition, the mechanisms that underlie these changes and the specific role of these processes in drug reinforcement, lapse, and relapse.
Similar articles
-
Blunted striatal response to monetary reward anticipation during smoking abstinence predicts lapse during a contingency-managed quit attempt.Psychopharmacology (Berl). 2016 Mar;233(5):751-60. doi: 10.1007/s00213-015-4152-2. Epub 2015 Dec 11. Psychopharmacology (Berl). 2016. PMID: 26660448 Free PMC article.
-
Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: an fMRI study.Neuropsychopharmacology. 2006 Dec;31(12):2728-38. doi: 10.1038/sj.npp.1301075. Epub 2006 Apr 5. Neuropsychopharmacology. 2006. PMID: 16598192
-
Longitudinal changes in reinforcement learning during smoking cessation: a computational analysis using a probabilistic reward task.Sci Rep. 2024 Dec 31;14(1):32171. doi: 10.1038/s41598-024-84091-y. Sci Rep. 2024. PMID: 39741189 Free PMC article.
-
Cognitive mechanisms underlying relapse to nicotine.Rev Neurosci. 2011;22(4):467-70. doi: 10.1515/RNS.2011.038. Epub 2011 Jul 27. Rev Neurosci. 2011. PMID: 21790507 Review.
-
Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials.Nicotine Tob Res. 2004 Aug;6(4):599-614. doi: 10.1080/14622200410001734067. Nicotine Tob Res. 2004. PMID: 15370156 Review.
Cited by
-
Prediction of smoking cessation with treatment: the emerging contribution of brain imaging research.Neuropsychopharmacology. 2015 May;40(6):1309-10. doi: 10.1038/npp.2015.31. Neuropsychopharmacology. 2015. PMID: 25868069 Free PMC article. No abstract available.
-
Lack of effect of transcranial direct current stimulation (tDCS) on short-term smoking cessation: Results of a randomized, sham-controlled clinical trial.Drug Alcohol Depend. 2019 Jan 1;194:244-251. doi: 10.1016/j.drugalcdep.2018.10.016. Epub 2018 Nov 13. Drug Alcohol Depend. 2019. PMID: 30497056 Free PMC article. Clinical Trial.
-
Smoke and mirrors: The overnight abstinence paradigm as an index of disrupted cognitive function.Psychopharmacology (Berl). 2016 Apr;233(8):1395-404. doi: 10.1007/s00213-016-4227-8. Epub 2016 Feb 15. Psychopharmacology (Berl). 2016. PMID: 26875757 Free PMC article.
-
Nicotine Abstinence Influences the Calculation of Salience in Discrete Insular Circuits.Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Feb;3(2):150-159. doi: 10.1016/j.bpsc.2017.09.010. Epub 2017 Oct 10. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018. PMID: 29529410 Free PMC article.
-
Phase IIb Trial of an α7 Nicotinic Receptor Partial Agonist With and Without Nicotine Patch for Withdrawal-Associated Cognitive Deficits and Tobacco Abstinence.J Clin Psychopharmacol. 2018 Aug;38(4):307-316. doi: 10.1097/JCP.0000000000000919. J Clin Psychopharmacol. 2018. PMID: 29912798 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources